Market revenue in 2022 | USD 441.2 million |
Market revenue in 2030 | USD 611.8 million |
Growth rate | 4.2% (CAGR from 2022 to 2030) |
Largest segment | Reagents & consumables |
Fastest growing segment | Analyzers |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Analyzers, Reagents & Consumables |
Key market players worldwide | BioMerieux SA, Roche Holding AG, Siemens Healthineers AG ADR, Abbott Laboratories, Horiba Ltd, QuidelOrtho Corp, Thermo Fisher Scientific Inc, Biomedica Diagnostics, Werfen, Diazyme Laboratories |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to thrombosis and hemostasis biomarkers market will help companies and investors design strategic landscapes.
Reagents & consumables was the largest segment with a revenue share of 65.5% in 2022. Horizon Databook has segmented the Latin America thrombosis and hemostasis biomarkers market based on analyzers, reagents & consumables covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing prevalence of CVDs & other chronic diseases, coupled with growing demand for highly advanced diagnostic tests is expected to boost the thrombosis & hemostasis biomarkers market in Latin America.
For instance, the CVD-related mortality in the region was 162.2 to 204.9 per 100,000 in 2021, according to the Journal of the American College of Cardiology. The occurrence of hypertension, obesity, and high blood cholesterol are observed to be frequent in the Latin American population.
This can be attributed to the rapid shift to the consumption of fat-rich food among individuals, a prominent feature observed in most developing economies. Hence, the risk of heart disease is high in this region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America thrombosis and hemostasis biomarkers market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America thrombosis and hemostasis biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account